1. Changes in EPA and DHA during supplementation with omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial. (14th October 2021) Authors: Myhre, P; Smith, E B; Kalstad, A A; Tveit, S; Laake, K; Smith, P; Nilsen, D W T; Tveit, A; Solheim, S; Arnesen, H; Seljeflot, I Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of omega-3 fatty acid supplementation on the risk of atrial fibrillation (AF) and micro-AF in the OMEMI trial. (3rd October 2022) Authors: Myhre, P; Berge, T; Kalstad, A; Tveit, S H; Laake, K; Schmidt, E B; Solheim, S; Arnesen, H; Seljeflot, I; Tveit, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gut leakage markers in response to strenuous exercise in patients with suspected coronary artery disease. (14th October 2021) Authors: Aune, S K; Cwikiel, J; Flaa, A; Arnesen, H; Solheim, S; Awoyemi, A; Troeseid, M; Seljeflot, I; Helseth, R Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Issue 24 (14th October 2009) Authors: Beitnes, J O; Hopp, E; Lunde, K; Solheim, S; Arnesen, H; Brinchmann, J E; Forfang, K; Aakhus, S Journal: Heart Issue: Volume 95:Issue 24(2009) Page Start: 1983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P482Markers of neutrophil extracellular traps are associated with adverse clinical outcome in patients with stable coronary artery disease. (23rd April 2018) Authors: Langseth, M S; Opstad, T B; Bratseth, V; Solheim, S; Arnesen, H; Pettersen, A A; Seljeflot, I; Helseth, R M Journal: Cardiovascular research Issue: Volume 114(2018)Supplement 1 Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Plaque and remodeling markers in coronary thrombi. (14th October 2021) Authors: Nordeng, J; Helseth, R; Aakra, S; Hoffmann, P; Schandiz, H; Roald, B; Bendz, B; Arnesen, H; Solheim, S; Seljeflot, I Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Screen-detected atrial fibrillation (AF) and "micro-AF" after myocardial infarction in patients 70–82 years and risk of cardiovascular events in the OMEMI trial. (3rd October 2022) Authors: Berge, T; Myhre, P L; Kalstad, A A; Laake, K; Tveit, S H; Onarheim, S; Solheim, S; Seljeflot, I; Arnesen, H; Tveit, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The inflammasome signaling axis in thrombi from STEMI patients is related to degree of myocardial injury. (25th November 2020) Authors: Nordeng, J; Helseth, R; Aakra, S; Hoffman, P; Schandiz, H; Roald, B; Bendz, B; Arnesen, H; Solheim, S; Seljeflot, I Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗